SKP.L Regulatory News (SKP)

10 Mar 2005 15:03

Skyepharma PLC10 March 2005 For Immediate Release 10 March 2005 SKYEPHARMA TO PRESENT AT SG COWEN'S 25th ANNUAL HEALTH CARE CONFERENCE IN BOSTON LONDON, UK, 10 March 2005 -- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announcestoday that the Company's Chief Executive Officer, Michael Ashton, will make apresentation at SG Cowen's 25th Annual Health Care Conference at the BostonMarriott Copley Place Hotel in Boston, Massachusetts. Mr. Ashton will deliverhis presentation on Tuesday, March 15, 2005 at 9.40 a.m. (EST). Investors mayaccess a live webcast of the presentation at www.skyepharma.com under theInvestor Relations tab. The presentation will be archived for 14 days. About SkyePharma PLC SkyePharma PLC develops pharmaceutical products benefiting from world-leadingdrug delivery technologies that provide easier-to-use and more effective drugformulations. There are now ten approved products incorporating SkyePharma'stechnologies in the areas of oral, injectable, inhaled and topical delivery,supported by advanced solubilisation capabilities. For more information, visitwww.skyepharma.com. For further information please contact:SkyePharma PLC +44 207 491 1777 Michael Ashton, Chief Executive OfficerPeter Laing, Director of Corporate Communications 44 207 491 5124Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000Tim Anderson / Mark Court This information is provided by RNS The company news service from the London Stock Exchange